Decrease in L-type pyruvate kinase activity in rat liver by some promoters of hepatocarcinogenesis.
S Yanagi, M Sakamoto, Y Ninomiya, T Kamiya
Index: J. Natl. Cancer Inst. 73(4) , 887-94, (1984)
Full Text: HTML
Abstract
A probably promoter-specific decrease of L-type pyruvate kinase (L-PK) in Wistar rat liver is described. The possibility of utilizing the decrease in L-PK activity for screening of hepatic promoters is discussed. A significantly decreased level of activity of L-PK was observed during continuous feedings of the hepatocarcinogen 3'-methyl-4-dimethylaminoazobenzene [(3'-MeDAB) CAS: 55-80-1], which initiates and promotes hepatocarcinogenesis, and of the known hepatic promoters phenobarbital [(PB) CAS: 50-06-6] and dichlorodiphenyltrichloroethane (CAS: 50-29-3) for at least 4 weeks. In contrast, if it occurred, the decrease in L-PK activity by the nonpromoting agents amobarbital (CAS: 57-43-2) and diphenylhydantoin. (CAS: 57-41-0) was temporary and almost overcome by the 4th week. The depression of L-PK activity caused by PB was reversible, was inversely correlated with PB concentration in the diet, and seemed to be organ-specific. Although hepatic promoters lowered L-PK activity in this study, data are so limited that a much more extensive study is necessary before a general conclusion can be drawn. In contrast to L-PK activity, the activity of K-type pyruvate kinase (K-PK) was induced by injections of the carcinogen diethylnitrosamine (CAS: 55-18-5) or the hepatotoxin CCl4 (CAS: 56-23-5) or by the feeding of 3'-MeDAB. However, feeding of PB or 2-methyl-4-dimethylaminoazobenzene (CAS: 54-88-6), which initiates but does not promote hepatocarcinogenesis, did not increase K-PK activity.
Related Compounds
Related Articles:
1984-10-01
[Indian J. Biochem. Biophys. 21(5) , 309-13, (1984)]
Toxic effects of 2-methyl-4-dimethylaminoazobenzene in normal and partially hepatectomized rats.
1984-02-01
[Chem. Biol. Interact. 48(2) , 221-35, (1984)]
1982-11-01
[Eur. J. Cancer Clin. Oncol. 18(11) , 1163-70, (1982)]
Early events during liver carcinogenesis involving two carcinogen:protein complexes.
1981-10-01
[Cancer Res. 41(10) , 4039-49, (1981)]
1983-08-23
[Biochim. Biophys. Acta 759(1-2) , 23-31, (1983)]